This website uses cookies primarily for visitor analytics. Certain pages will ask you to fill in contact details to receive additional information. On these pages you have the option of having the site log your details for future visits. Indicating you want the site to remember your details will place a cookie on your device. To view our full cookie policy, please click here. You can also view it at any time by going to our Contact Us page.

Close

CBD sector on standby for FSA list of permitted products

21 February 2022

The UK’s consumer health sector is set for its biggest shake-up in more than a decade when the Food Standards Agency (FSA) releases its public list of cannabinoid (CBD) products permitted for sale to consumers. 

Only products on the list will be able to stay on the market, while those not included will have to be taken off sale. It is anticipated that Trading Standards officers will apply the new rules immediately, which means companies that continue to sell unlisted CBD products will be putting themselves at risk of enforcement action.

Publication of the list is imminent. The Association for the Cannabinoid Industry (ACI), the trade body for the UK’s CBD sector, has stepped in to develop an online resource – www.UKCBDList.com – to enable consumers, retailers and health practitioners to ensure they are buying and selling only permitted products.

The FSA has been evaluating the safety of CBD products for over 18-months, in line with the UK’s Novel Food requirements. This assessment process was accessible to any CBD product formulated for oral use that was on sale in the UK on or before 13 February 2020, with the deadline for applications fixed at 31 March 2021.


Print this page | E-mail this page